Merck said on Thursday the Food and Drug Administration has approved Lipfendra, a PCSK9 inhibitor cholesterol pill.
The Food and Drug Administration on Thursday approved a new cholesterol pill from Merck that works in a different way from statins.
Subscribe to read this story ad-free
Get unlimited access to ad-f⌠[+1888 chars]
Discussion (0)
No comments yet. Be the first to share your thoughts!
Join the Conversation
You need to be logged in to leave a comment.
Sign In Create Account